CNBC: FDA halts use of Johnson & Johnson vaccine due to rare blood clotting issues in six women
The FDA said the recommendation for the J&J vaccine is “out of an abundance of caution.”
This is a setback for vaccines in the United States.
JUST IN: The CDC and FDA recommend a pause for Johnson & Johnson's Covid-19 vaccine over "six reported US cases of a rare and severe type of blood clot."https://t.co/L1w1iH5DGl pic.twitter.com/r5UKSFJcyi
— CNN This Morning with Kasie Hunt (@CNNThisMorning) April 13, 2021
